MD Anderson Cancer Center Orlando (Fla.) announced the ground breaking of its new proton therapy center. The Proton Therapy Center at MD Anderson Cancer Center Orlando will treat cancers of the brain, ...

A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announced that it ...

Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for ...

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...

Concord Medical Services Holdings, a Beijing-based network of radiotherapy and diagnostic imaging centers, has acquired a 19.98 percent indirect ownership interest in the The University of Texas MD ...

Concord Medical Services Holdings Limited ("Concord Medical," or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of ...

Major themes include advances in actionable biomarkers in pancreatic cancer, proton therapy, artificial intelligence and theranostics MD Anderson researchers will present more than 65 abstracts, ...

At five years, 90.9% of proton patients were alive compared to 81% with traditional radiation Proton therapy also showed benefits in quality of life, such as less feeding tube dependence, less ...